The biologics omalizumab, mepolizumab, benralizumab, and dupilumab have similar effectiveness in improving lung function in severe asthma.
Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback